This week the Governor welcomed Bausch & Lomb to its new global pharmaceutical headquarters in Madison.  The company’s 30,000-square-foot facility will create 70 new full-time, high-paying jobs in New Jersey.

“Bausch & Lomb’s decision to locate its pharmaceutical headquarters in New Jersey demonstrates the state remains an attractive location for major pharmaceutical companies to grow and thrive,” the Governor said at the ribbon-cutting ceremony. “New Jersey is proud to welcome Bausch & Lomb to Madison.” 

New Jersey’s vibrant pharmaceutical and biotechnology industries were a key factor in Bausch & Lomb’s decision to establish its pharmaceutical headquarters in New Jersey.  According to the Healthcare Institute of New Jersey, 15 of the world’s top 25 pharmaceutical companies have either World or North American headquarters or significant operations in New Jersey.

“Establishing our global pharmaceutical headquarters in New Jersey opens up opportunities to partner with other pharmaceutical companies and to drive commercialization of new products,” said Gerald M. Ostrov, CEO of Bausch & Lomb. “We're looking forward to growing our presence here, which in turn will help us bring the best possible eye health products and services to people around the world.”

The new Madison facility establishes Bausch & Lomb’s pharmaceutical headquarters within a global epicenter for the industry.